Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?
Graphical abstract
Keywords
Antiphospholipid antibodies
COVID-19
COVID-19 vaccine
Immunothrombosis
Cited by (0)
Rossella Talotta received her Ph.D. in Rheumatology from the University of Padua, Italy. She is doing her postdoctoral training at the University of Messina, Italy. She is currently working at collaborative research projects with the University of Aarhus, Denmark, and the University of Pennsylvania, Philadelphia, USA, aiming to study the immunogenetic and microbial pathogenesis of autoimmune diseases. She wrote more than fifty papers and abstracts published on international peer-reviewed journals. She also received a number of awards from the Italian Society of Rheumatology and Lundbeckfonden for leading research projects in the field of Rheumatology and Immunology.
© 2021 Elsevier Ltd. All rights reserved.